. Compound 3c retained bactericidal activity under nutrient-starvation conditions and outperformed isoniazid (INH) in a dormancy model. Cytotoxicity assays in HepG2 and Vero E6 cells showed low toxicity (IC₅₀ > 100 μM). These findings identify 3c as a promising lead scaffold for anti-TB drug development.
Santos-Júnior et al. (Fri,) studied this question.